Sciwind Biosciences APAC CO Pty. Ltd.

Quick facts

Phase 3 pipeline

• XW003 · Diabetes
  XW003 is a small molecule inhibitor of the sodium-glucose cotransporter 2 (SGLT2).

Phase 1 pipeline

• Oral ecnoglutide tablet
• T2026

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Sciwind Biosciences APAC CO Pty. Ltd. portfolio CI brief
• Sciwind Biosciences APAC CO Pty. Ltd. pipeline updates RSS